Light-Activated Amino Acids Yield Psychedelic-Style Brain Drugs Without Hallucinations

UC Davis researchers developed a light-driven method that combines amino acids with tryptamine and, after UV exposure, reshapes them into new molecules that activate the serotonin 5-HT2A receptor and may offer psychedelic-like brain benefits without altering perception. In mice, the leading compound fully activated 5-HT2A but did not induce hallucinogenic behaviors (head-twitch responses), leading researchers to pursue further studies on how other serotonin receptors might modulate or suppress perceptual effects.